Carregant...

Enhancing cancer immunotherapy with nanomedicine

Therapeutic targeting of the immune system in cancer is now a clinical reality and marked successes have been achieved, most notably through the use of checkpoint blockade antibodies and chimeric antigen receptor T cell therapy. However, efforts to develop new immunotherapy agents or combination tre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Rev Immunol
Autors principals: Irvine, Darrell J., Dane, Eric L.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7536618/
https://ncbi.nlm.nih.gov/pubmed/32005979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-019-0269-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!